ARTELO BIOSCIENCES, INC. — Form 8-K
Filed October 9, 2026 · analyzed by the 8-K Agent
8-K
— Neutral
significance 8/100
What the filing says
Artelo Biosciences filed an 8-K on 2026-10-09 reporting other events. The actual substance of Item 8.01 is not disclosed in the provided document text—only the filing metadata and XBRL taxonomy data are shown. No specific counterparties, amounts, dates, or business changes are stated.
Why this rating
Cannot assess substance; filing metadata only. Company scale ~$9.3M market cap limits impact of routine disclosure.
Extracted items
See more from October 9, 2026.
EDGAR·FLOW summarizes public SEC EDGAR filings with automated analysis. Materiality scores and stock-impact predictions are algorithmically generated and are not investment advice. Always verify against the source filing on SEC.gov.